Skip to main content
DaehanPharmaceutical logo

DaehanPharmaceutical — Investor Relations & Filings

Ticker · 023910 ISIN · KR7023910003 KO Manufacturing
Open in API
Filings indexed 297 across all filing types
Latest filing 2024-08-22 Director's Dealing
Country KR South Korea
Listing KO 023910

About DaehanPharmaceutical

https://www.dhnp.co.kr/

Daehan Nupharm is a pharmaceutical company engaged in the research, development, and manufacturing of a diverse portfolio of healthcare products. The company's business is structured around four core areas: human pharmaceuticals, offering a range of therapeutic treatments; animal health products for both companion and livestock animals; advanced bio-pharmaceuticals, with a focus on next-generation technologies like cell therapy; and health functional foods. Established initially in the animal health sector, the company leverages its dedicated Central and Bio Research Institutes to drive innovation and develop solutions for global markets. The R&D efforts concentrate on strengthening technological capabilities and advancing new treatment modalities.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details share transactions (purchases) made by a director/major shareholder (Lee Yoon-woo) of Daehan Pharmaceutical Co., Ltd. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports insider share transactions.
2024-08-22 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-annual Report) for '대한약품공업주식회사' (Daihan Pharm Co., Ltd.) covering the period from January 1, 2024, to June 30, 2024. It contains detailed financial information, business operations, management analysis, and governance disclosures, which are characteristic of an interim financial report. It is not an announcement of a report, but the report itself. H1 2024
2024-08-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details share transactions (purchases) by an executive (Lee Yoon-woo) of Daehan Pharmaceutical Co., Ltd. This type of filing is a standard regulatory requirement for reporting insider trading or changes in ownership by company directors and major shareholders, which corresponds to the 'Director's Dealing' (DIRS) category.
2024-08-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This is a standard regulatory filing used to disclose insider trading or changes in share ownership by company directors and executives. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2024-08-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details share transactions (specifically '장내매수' or on-market purchases) by a company director (Lee Yoon-woo) of Daehan Pharmaceutical Co., Ltd. This type of filing is a standard regulatory requirement for insider trading/director dealings in South Korea, which corresponds to the 'Director's Dealing' category.
2024-08-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities (Financial Supervisory Service/Korea Exchange). It details the share acquisition (장내매수) by an executive (Lee Yoon-woo) of Daehan Pharmaceutical Co., Ltd. This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) as it reports personal share transactions by company directors/executives.
2024-07-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.